Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
X0406334	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs(5)	New Drug Application	2004-11-08	江苏恒瑞医药股份有限公司	Jiangsu Hengrui Pharmaceuticals Co Ltd	Certificate Issued	2005-08-31	view
JYHZ2000253	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	License Renew	2020-11-18	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Completed-Pending Withdrawn	2021-03-18	view
JYHZ2000252	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	License Renew	2020-11-18	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Completed-Pending Withdrawn	2021-03-18	view
JYHZ2000251	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	License Renew	2020-11-18	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Completed-Pending Withdrawn	2021-03-18	view
JYHZ0700095	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	License Renew	2007-05-30	Pfizer Italia s.r.l.	Pfizer Italia SRL	Certificate Issued	2008-03-14	view
JYHB2300742	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-12-22					view
JYHB2300741	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-12-22					view
JYHB2300669	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-11-21					view
JYHB2300668	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-11-21					view
JYHB2300667	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-11-21					view
JYHB2300061	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-01-20					view
JYHB2300060	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-01-20					view
JYHB2300059	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2023-01-20					view
JYHB2002329	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs(1)	Supplementary Application	2020-11-18	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-02-09	view
JYHB2002328	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2020-11-18	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-02-09	view
JYHB2002327	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2020-11-18	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-02-09	view
JYHB2001783	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2020-09-17	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-11-20	view
JYHB2001782	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2020-09-17	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-11-20	view
JYHB2001780	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2020-09-17	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-11-20	view
JYHB2000936	盐酸伊立替康注射液	irinotecan hydrochloride	Injection	Chemical Drugs	Supplementary Application	2020-06-29	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-06-30	view